RAPT Therapeutics Shares More Than Double Premarket on License Agreement for Allergy Treatment
RAPT Therapeutics的股票因过敏治疗的许可证协议在盘前交易中涨幅超过一倍
RAPT Therapeutics Shares More Than Double Premarket on License Agreement for Allergy Treatment
RAPT Therapeutics的股票因过敏治疗的许可证协议在盘前交易中涨幅超过一倍
译文内容由第三方软件翻译。
使用浏览器的分享功能,分享给你的好友吧